Compounds > azacitidine

azacitidine and mocetinostat

azacitidine has been researched along with mocetinostat in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Borden, EC; Cheriyath, V; Luszczek, W; Mekhail, TM1
Barlogie, B; Garg, T; Hoerring, A; Moreno-Bost, A; Prentice, HG; Shaughnessy, J; Stone, K; Szmania, S; Szymonifka, J; van Rhee, F1
Mukherjee, S; Ornstein, MC; Sekeres, MA1
Dai, J; Ge, P; Gong, X; Lin, L; Xing, Y; Yang, C; Yi, J; Zhang, L1
Bae, G; Johnson, HL; Jones, P; Mani, SA; Powell, RT; Roarty, KP; Rosen, JM; Stephan, CC; Stossi, F; Strempfl, M; Toneff, MJ; Yuan, X; Zhao, N1

Reviews

1 review(s) available for azacitidine and mocetinostat

ArticleYear
More is better: combination therapies for myelodysplastic syndromes.
    Best practice & research. Clinical haematology, 2015, Volume: 28, Issue:1

    Topics: Antineoplastic Agents; Azacitidine; Benzamides; Clinical Trials as Topic; Decitabine; Disease Progression; Drug Therapy, Combination; Gene Expression; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Lenalidomide; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Pyrimidines; Thalidomide; Valproic Acid; Vorinostat

2015

Other Studies

6 other study(ies) available for azacitidine and mocetinostat

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:8

    Topics: Apoptosis; Azacitidine; Benzamides; Cell Cycle; Cell Line, Tumor; Cell Survival; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Damage; DNA Methylation; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Indoles; Interferons; Lung Neoplasms; Panobinostat; Phosphorylation; Pyrimidines; Small Cell Lung Carcinoma

2010
Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103.
    Cytotherapy, 2011, Volume: 13, Issue:5

    Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Benzamides; Cell Line, Tumor; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Male; Multiple Myeloma; Neoplasm Proteins; Pyrimidines; Secondary Prevention; T-Lymphocytes, Cytotoxic

2011
Anti-oxidative and anti-inflammatory benefits of the ribonucleoside analogue 5-azacitidine in mice with acetaminophen-induced toxic hepatitis.
    International immunopharmacology, 2017, Volume: 48

    Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Antioxidants; Azacitidine; Chemical and Drug Induced Liver Injury; Glutathione; Interleukin-6; Liver; Male; Malondialdehyde; Mice, Inbred C57BL; Nitric Oxide; Oxidative Stress; Peroxidase; Tumor Necrosis Factor-alpha

2017
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition.
    Nature communications, 2021, 07-12, Volume: 12, Issue:1

    Topics: Animals; Antineoplastic Agents; Azacitidine; Benzamides; Drug Screening Assays, Antitumor; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Image Processing, Computer-Assisted; Mammary Neoplasms, Animal; Mesoderm; Mice, Inbred BALB C; MicroRNAs; Neoplasm Proteins; Organoids; Pyrimidines; Reproducibility of Results; Small Molecule Libraries

2021